Conversely, previous studies from our lab and other groups evidenced that DGKα inhibition is an efficient way to restore T cell responses when the TCR signalling strength is reduced by anergy (40) or SAP absence in XLP-1 patients (14). The gene discussed is SH2D1A; the disease is X-linked lymphoproliferative syndrome.